Patients with celiac disease have a higher incidence of Clostridioides (formerly Clostridium) difficile infection than the general population, even after accounting for traditional risk factors for developing the sometimes life-threatening diarrheal infection. So found a large database study that its authors say is the first in the United States to determine this association, drawing attention to the need for clinicians to consider the diagnosis for celiac patients with new or recurring diarrhea.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Results of the study conducted by a team of Cleveland Clinic researchers were presented at two meetings in October 2022: the American College of Gastroenterology annual meeting and the International Celiac Disease Symposium.
“Because of this study’s findings, I now test all celiac patients who have persistent diarrhea while following a gluten-free diet,” says lead study investigator Alberto Rubio Tapia, MD, a gastroenterologist and Director of Cleveland Clinic’s Celiac Disease Program. “Testing is simple and quick, and appropriate treatment can help prevent prolonged symptoms, colectomy and even death.”
The study investigators searched electronic health record data using Explorys (a platform originally developed by Cleveland Clinic and now part of IBM Watson Health) from 2017 to 2022. Data were obtained from 26 major healthcare systems in the U.S.: 90,060 adult patients with celiac disease and 25,807,720 without celiac disease (controls) were identified.
Key findings:
Dr. Rubio Tapia notes that this is the largest study to date examining the connection between C. difficile and celiac disease, strengthening its findings. Although the association is modest after controlling for risk factors, he adds, it is important for doctors to keep in mind due to the seriousness of untreated C. difficile infection.
He highlights the following major takeaways:
“Knowing that celiac patients have a propensity to develop C. difficile infection and that treatment is highly effective, the big mistake would be not to look for it with unexplained diarrhea,” emphasizes Dr. Rubio Tapia.
Why patients with celiac disease have increased susceptibility to C. difficile infection is still an open question, according to Dr. Rubio Tapia. That celiac patients tend to be older, female and white, frequently use antibiotics and acid suppressive therapy, and are likelier to have inflammatory bowel disease, all contribute to the higher rates, he notes. But he suspects that gut microbiome balance may be different in patients with celiac disease, possibly explaining the increased risk beyond those factors.
“Our group is examining how the microbiome in patients with celiac disease may differ from healthy controls and the possible impacts of a gluten-free diet on the microbiome,” he says.
Results from the large, single-center, retrospective study have multiple implications for preventive care
Careful risk stratification is key
Findings support the safety of the technique
Insights from murine models could help guide care for patients
Reviewing how the drug can be incorporated into care
Largest, longest analysis to date shows greater weight loss and fewer diabetes medications needed
The importance of raising awareness and taking steps to mitigate these occurrences
New research indicates feasibility and helps identify which patients could benefit